John G. McHutchison, A.O., M.D., is a notable figure in the biotech world, serving as the CEO of Assembly Biosciences from 2019 until his retirement in 2022. With a medical background and a focus on innovative research, he previously led...
John G. McHutchison, A.O., M.D., is a notable figure in the biotech world, serving as the CEO of Assembly Biosciences from 2019 until his retirement in 2022. With a medical background and a focus on innovative research, he previously led research and development at Gilead Sciences, where he was instrumental in filing multiple New Drug Applications for treatments like hepatitis C. McHutchison was also recognized for his significant contributions to medical research, receiving the title of Officer of the Order of Australia in 2018. He holds degrees in medicine and surgery from the University of Melbourne and has an extensive track record in academic and clinical roles, including positions at Duke University Medical Center. After stepping down as CEO, he transitioned to a member of the Board of Directors. His leadership style reflects a deep understanding of both the scientific and business aspects of the healthcare industry, making his insights valuable in corporate governance. During his tenure, he accrued impressive stock options, signaling confidence in the company’s performance and future potential.